TLSI
TriSalus Life Sciences, Inc. · Healthcare
CEO and President Mary T Szela sold $79K of TriSalus Life Sciences, Inc.
Sold$79,383
$3.91Price
20,302Shares
−3%Stake
What TLSI did after the filing
- The stock from Fri, Mar 20 close, $3.93
- +13.2%
- S&P 500, same days
- +10.7%
Measured over 30 trading days, to the May 4 close.
Traded Wed, Mar 11. Filed Fri, Mar 20, 12:25 PM ET, during the session. Returns use the Mar 20 close and the May 4 close. Not investment advice.